Aptus Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $694K | Buy |
10,060
+2,540
| +34% | +$175K | 0.01% | 599 |
|
|
2025
Q1 | $522K | Buy |
7,520
+479
| +7% | +$33.3K | 0.01% | 626 |
|
|
2024
Q4 | $606K | Buy |
7,041
+3,267
| +87% | +$281K | 0.01% | 577 |
|
|
2024
Q3 | $449K | Buy |
3,774
+940
| +33% | +$112K | 0.01% | 563 |
|
|
2024
Q2 | $404K | Sell |
2,834
-232
| -8% | -$33.1K | 0.01% | 545 |
|
|
2024
Q1 | $394K | Buy |
+3,066
| New | +$394K | 0.01% | 559 |
|